ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,817Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 2170

$2.67M Total Retail Price of All Prescriptions

Rank: 7 out of 2170

755 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 755 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 755 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 21,257 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 1,061 692 1 2
AMLODIPINE BESYLATE 995 796 2 4
SIMVASTATIN 791 594 3 1
LISINOPRIL 781 562 4 3
WARFARIN SODIUM 752 517 5 15
FUROSEMIDE 710 538 6 6
HYDROCODONE-ACETAMINOPHEN 640 372 S3 7 7
CITALOPRAM HBR 624 458 8 19
METOPROLOL TARTRATE 622 382 9 10
MIRTAZAPINE 571 450 10 46
NOVOLOG 558 394 11 98
LEVOTHYROXINE SODIUM 547 385 12 5
DONEPEZIL HCL 491 413 13 32
GABAPENTIN 458 274 14 14
RANITIDINE HCL 421 314 15 40
NAMENDA 394 347 16 48
CARVEDILOL 383 260 17 26
PRAVASTATIN SODIUM 361 241 18 11
DIVALPROEX SODIUM 353 237 19 91
METOPROLOL SUCCINATE 336 241 20 13
LANTUS 307 214 21 51
TRAMADOL HCL 293 230 22 18
CLONIDINE HCL 286 173 23 54
POTASSIUM CHLORIDE 272 192 24 16
CYMBALTA 265 141 25 44
LYRICA 258 145 26 90
ATORVASTATIN CALCIUM 256 161 27 12
TRAVATAN Z 242 169 28 181
TAMSULOSIN HCL 236 170 29 33
DIOVAN 232 148 30 53
SERTRALINE HCL 228 131 31 25
ZOLPIDEM TARTRATE 224 113 32 17
METFORMIN HCL 223 109 33 8
METOCLOPRAMIDE HCL 215 89 34 127
BACLOFEN 214 58 35 137
RISPERIDONE 211 96 36 73
OLANZAPINE 206 110 37 139
QUETIAPINE FUMARATE 205 106 38 88
ALLOPURINOL 204 150 39 29
POLYETHYLENE GLYCOL 3350 196 174 40 63
ADVAIR DISKUS 191 134 41 45
FENTANYL 180 68 S2 42 87
ATENOLOL 177 143 43 23
LEVETIRACETAM 171 72 44 109
ESCITALOPRAM OXALATE 170 117 45 75
FLUTICASONE PROPIONATE 169 106 46 30
SANTYL 167 90 47 221
TRAZODONE HCL 167 53 47 38
PROMETHAZINE HCL 165 72 R 49 70
OXYBUTYNIN CHLORIDE ER 164 74 50 148
KLOR-CON M20 161 106 51 68
MELOXICAM 158 118 52 28
HYDRALAZINE HCL 155 103 53 84
FAMOTIDINE 155 96 53 96
SPIRIVA 147 110 55 49
NUEDEXTA 143 94 56 308
MORPHINE SULFATE ER 142 72 S2 57 124
ALENDRONATE SODIUM 141 114 58 36
DIVALPROEX SODIUM ER 137 59 59 189
CLOPIDOGREL 136 100 60 37
GLIPIZIDE 136 110 60 62
PLAVIX 136 99 60 58
NYSTATIN 134 80 63 160
LOSARTAN POTASSIUM 128 93 64 21
PREDNISONE 127 92 65 41
GLUCAGEN 126 88 66 391
GLIMEPIRIDE 125 100 67 31
PANTOPRAZOLE SODIUM 121 75 68 39
ABILIFY 115 63 69 159
LEVEMIR FLEXPEN 114 72 70 185
ARICEPT 112 94 71 316
CLONIDINE 111 72 72 263
TRANSDERM-SCOP 110 79 73 330
NOVOLIN R 110 68 73 149
VENLAFAXINE HCL ER 110 56 73 97
LATANOPROST 109 78 76 194
ISOSORBIDE MONONITRATE ER 108 88 77 50
BENZTROPINE MESYLATE 106 26 R 78 172
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 43 78 95
CARBIDOPA-LEVODOPA 104 67 80 110
HYDROCHLOROTHIAZIDE 102 78 81 9
IPRATROPIUM-ALBUTEROL 98 81 82 131
FINASTERIDE 98 86 82 122
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 69 84 20
DOXYCYCLINE HYCLATE 97 50 84 100
LACTULOSE 96 56 86 125
EXELON 96 92 86 119
DIOVAN HCT 96 84 86 76
OXYCODONE HCL 95 18 S2 89 56
CELEBREX 95 60 89 89
TIZANIDINE HCL 95 25 89 123
NOVOLOG MIX 70-30 95 60 89 261
MEGACE ES 95 70 R 89 325
VIMPAT 94 23 94 316
OXYCONTIN 93 51 S2 95 146
NEXIUM 91 56 96 22
TRIAMCINOLONE ACETONIDE 91 53 96 128
ACTOS 89 48 98 108
VENLAFAXINE HCL 88 25 99 225
BRIMONIDINE TARTRATE 88 66 99 278
HUMALOG 87 49 101 190
CIPROFLOXACIN HCL 87 60 101 69
FLUOXETINE HCL 86 56 103 59
LEVOFLOXACIN 86 43 103 99
PHENYTOIN SODIUM EXTENDED 85 54 105 142
AMANTADINE 83 24 106 427
HYDROXYZINE HCL 80 40 R 107 173
LEVEMIR 79 57 108 195
DIGOXIN 75 70 109 72
LABETALOL HCL 75 54 109 208
ONDANSETRON HCL 75 47 109 230
LOSARTAN-HYDROCHLOROTHIAZIDE 74 49 112 42
SYNTHROID 74 64 112 27
SEROQUEL 73 50 114 168
LEXAPRO 73 45 114 198
CYCLOBENZAPRINE HCL 73 37 R 114 52
CHLORHEXIDINE GLUCONATE 72 45 117 374
PAROXETINE HCL 70 47 118 65
AVELOX 70 35 118 271
AGGRENOX 70 48 118 169
DEXILANT 68 55 121 199
CRESTOR 68 56 121 24
RISPERDAL CONSTA 68 61 121 260
DORZOLAMIDE HCL 67 46 124 377
LANTUS SOLOSTAR 67 44 124 79
COLCRYS 67 40 124 140
SPIRONOLACTONE 66 40 127 71
ALBUTEROL SULFATE 66 46 127 167
PRADAXA 64 42 129 258
DILTIAZEM 24HR CD 63 42 130 82
DILTIAZEM HCL 63 33 130 224
OXYCODONE-ACETAMINOPHEN 62 49 S2 132 60
LAMOTRIGINE 61 26 133 136
AMITIZA 60 21 134 267
AMLODIPINE BESYLATE-BENAZEPRIL 59 22 135 67
OXYBUTYNIN CHLORIDE 58 48 136 164
RENVELA 58 23 136 303
DILTIAZEM ER 57 38 138 133
CARBAMAZEPINE 55 44 139 204
HALOPERIDOL 55 19 139 176
NITROFURANTOIN MONO-MACRO 55 32 139 196
SENSIPAR 54 20 142 404
ZETIA 54 30 142 78
ISOSORBIDE DINITRATE 53 40 144 229
ENALAPRIL MALEATE 53 34 144 64
ROPINIROLE HCL 52 41 146 92
BUPROPION XL 52 33 146 170
PATANOL 52 39 146 339
LUMIGAN 52 41 146 315
VESICARE 51 39 150 237
CEPHALEXIN 51 23 150 120
FLUCONAZOLE 51 30 150 158
SUCRALFATE 50 27 153 197
ARANESP 50 37 153 408
ONGLYZA 50 38 153 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.